Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Envisia Therapeutics

Envisia Therapeutics is a biotechnology company developing ocular therapies founded in 2013.

Overview Structured Data Issues Contributors Activity

envisiatherapeutics.com

Is a

Organization

Company

Company attributes

Industry

Location

AngelList URL

angel.co/envisia-therapeutics

Pitchbook URL

pitchbook.com/profiles.../60270-13

Spun Out From

Liquidia Technologies

Number of Employees (Ranges)

11 – 500

Investors

Pappas Capital

Morningside Venture Capital

Wakefield Group

Morningside Group

NEA (New Enterprise Associates)

Canaan Partners

Founded Date

2013

Total Funding Amount (USD)

25,000,000

Latest Funding Round Date

November 12, 2013

Latest Funding Type

Series A

Wellfound ID

envisia-therapeutics

Other attributes

Company Operating Status

Closed

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

Liquidia spins out new biotech with $25M A round

https://www.fiercebiotech.com/venture-capital/liquidia-spins-out-new-biotech-25m-a-round

Web

November 12, 2013

References

Find more companies like Envisia Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API